Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis-Reference-Cited by-同舟云学术

Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis

Published:2019-11 Issue:6 Volume:29 Page:1482-1498.e4
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Zeng Yi,Qiu Rongfang,Yang Yang,Gao Tianyang,Zheng Yu,Huang Wei,Gao Jie,Zhang Kai,Liu Ruiqiong,Wang Shuang,Hou Yongqiang,Yu Wenqian,Leng Shuai,Feng Dandan,Liu Wei,Zhang Xi,Wang Yan

Funder

Major State Basic Research Development Program of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference48 articles.

1. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase;Abu-Farha;Mol. Cell. Proteomics,2008

2. Biology of breast cancer during pregnancy using genomic profiling;Azim;Endocr. Relat. Cancer,2014

3. Non-histone protein methylation as a regulator of cellular signalling and function;Biggar;Nat. Rev. Mol. Cell Biol.,2015

4. Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex;Brown;Mol. Cancer,2006

5. SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation;Buchwald;Oncogene,2013

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylation modification of non-histone proteins in breast cancer: An emerging targeted therapeutic strategy;Pharmacological Research;2024-10

2. Inhibition of SMYD2 attenuates paraquat-induced pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition through the GLIPR2/ERK/p38 axis;Pesticide Biochemistry and Physiology;2024-06

3. Methylation of ESCRT-III components regulates the timing of cytokinetic abscission;Nature Communications;2024-05-13

4. Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer;Cell Reports;2024-05

5. Epigenetic regulators controlling osteogenic lineage commitment and bone formation;Bone;2024-04